arbekacin and daptomycin

arbekacin has been researched along with daptomycin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akins, RL; Rybak, MJ	1
LaPlante, KL; Rybak, MJ	1
Chin, JN; LaPlante, KL; Leuthner, KD; Rybak, MJ	1
Niki, Y	1
Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K	1

Reviews

1 review(s) available for arbekacin and daptomycin

Article	Year
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Apr-10, Volume: 101, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin	2012

Article

Year

[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Apr-10, Volume: 101, Issue:4

Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin

2012

Other Studies

4 other study(ies) available for arbekacin and daptomycin

Article	Year
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7 Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2000
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagnostic microbiology and infectious disease, 2004, Volume: 50, Issue:2 Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin	2004
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline	2006
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors	2016